FDA product code KPO: Dialysate Concentrate For Hemodialysis (Liquid Or Powder)

KPO is the FDA product code for dialysate concentrate for hemodialysis (liquid or powder). It is a Class II device, regulated under 21 CFR 876.5820 and reviewed by the Gastroenterology and Urology panel. FDA has cleared 124 510(k) submissions under KPO, 12 in the last five years, from 68 different applicants. The average 510(k) review took 141 days (median 90); 115 days on average over the last three years. FDA has posted 113 recalls for KPO devices, 25 initiated in the last five years.

Classification

FieldValue
Device nameDialysate Concentrate For Hemodialysis (Liquid Or Powder)
Device classClass II
Regulation21 CFR 876.5820
Review panelGU — Gastroenterology and Urology
Medical specialtyGastroenterology, Urology
Premarket route510(k)
Life-sustaining or supportingYes

510(k) clearances per year for KPO

YearClearancesAvg. review days
20173168
20182266
20205290
2021123
20222489
20233199
20243120
2025288
20262138

Compare with all 510(k) review times · Search every KPO clearance

Top KPO applicants

ApplicantClearancesLatest
Fresenius Medical Care Renal Therapies Group, LLC102026-01-29
Nxstage Medical, Inc.62024-01-18
Gambro Renal Products62012-05-25
Baxter Healthcare Corp62009-08-07
Di-Chem, Inc.52022-08-12

63 more applicants have KPO clearances. See the full list in Caduvo.

Most recent KPO clearances

510(k)ApplicantDeviceDecision dateReview days
K260799Nipro Technical Solutions, IncoporatedNipro Dry Acid Concentrate Mixer2026-08-19161
K253462Fresenius Medical Care Renal Therapies Group, LLCNaturaLyte® Dry Bicarbonate Concentrate (08-4112-2)2026-01-29114
K252180Fresenius Medical Care Renal Therapies Group, LLCBicarby Dialysate RFP-404 (RFP-404-W); Bicarby Dialysate RFP-403 (RFP-403-W); Bicarby Dialysate RFP-403 (RFP-403-G); Bicarby Dialysate RFP-453 (RFP-453-W); Bicarby Dialysate RFP-453 (RFP-453-G); Bicarby Dialysate RFP-454 (RFP-454-W); Bicarby Dialysate RFP-454 (RFP-454-G); Bicarby Dialysate RFP-456 (RFP-456-W)2025-09-0960
K243786Fresenius Medical Care Renal Therapies Group, LLCBicarby Dialysate RFP-402 (RFP-402-G); Bicarby Dialysate RFP-400 (RFP-400-G); Bicarby Dialysate RFP-407 (RFP-407-G); Bicarby Dialysate RFP-401 (RFP-401-G); Bicarby Dialysate RFP-404 (RFP-404-G); Bicarby Dialysate RFP-456 (RFP-456-G); Ci-Ca Dialysate 2K (RFP-457-G); Ci-Ca Dialysate 4K (RFP-458-G)2025-04-04116
K240920Deka Research and DevelopmentHemoCare Bicarbonate Concentrate Set (BCS)2024-07-1299

Recalls for KPO devices

113 product recalls in 45 recall events; 25 initiated in the last five years and 56 still open. Most recent: 2026-08-05.

YearRecalls
20172
201813
20193
202032
20214
20226
20242
20258
20269

Frequently asked questions

What is FDA product code KPO?

KPO is the FDA product code for dialysate concentrate for hemodialysis (liquid or powder). It is a Class II device, regulated under 21 CFR 876.5820 and reviewed by the Gastroenterology and Urology panel.

What device class is KPO?

Class II, regulation 21 CFR 876.5820. Typical premarket route: 510(k).

How long does a 510(k) take for product code KPO?

Across 124 cleared submissions the average was 141 days from receipt to decision (median 90).

Which companies have the most KPO clearances?

Fresenius Medical Care Renal Therapies Group, LLC (10); Nxstage Medical, Inc. (6); Gambro Renal Products (6); Baxter Healthcare Corp (6); Di-Chem, Inc. (5).

Have KPO devices been recalled?

Yes: 113 product recalls across 45 recall events; the most recent began 2026-08-05.

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Gastroenterology and Urology product codes · FDA product code lookup · 510(k) database search · 510(k) review times